BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1393@pharmaconomics
DTSTAMP:20260707T021631Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:ATHE Phase 3 — ATH434 (estimated date)
DESCRIPTION:Phase 3 trial results for ATH434 in Multiple System Atrophy are due ~ Dec 31\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1131343/000143774926019907/ex_974330.htm\n\nTrack it: https://pharmaconomics.com/e/1393
URL:https://pharmaconomics.com/e/1393
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ATHE catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR